Northern Trust’s Plus Therapeutics PSTV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $47.7K | Hold |
11,732
| – | – | ﹤0.01% | 4252 |
|
|
2025
Q4 | $150K | Buy |
11,732
+1,112
| +10% | +$16.8K | ﹤0.01% | 4061 |
|
|
2025
Q3 | $182K | Buy |
+10,620
| New | +$130K | ﹤0.01% | 4010 |
|
|
2023
Q2 | – | Sell |
-154
| Closed | -$16.7K | – | 4580 |
|
|
2023
Q1 | $16.7K | Buy |
154
+68
| +79% | +$9.15K | ﹤0.01% | 4477 |
|
|
2022
Q4 | $10.2K | Hold |
86
| – | – | ﹤0.01% | 4572 |
|
|
2022
Q3 | $14K | Hold |
86
| – | – | ﹤0.01% | 4604 |
|
|
2022
Q2 | $17K | Hold |
86
| – | – | ﹤0.01% | 4645 |
|
|
2022
Q1 | $32K | Hold |
86
| – | – | ﹤0.01% | 4609 |
|
|
2021
Q4 | $34K | Hold |
86
| – | – | ﹤0.01% | 4650 |
|
|
2021
Q3 | $61K | Sell |
86
-22
| -20% | -$16.8K | ﹤0.01% | 4497 |
|
|
2021
Q2 | $104K | Buy |
+108
| New | +$97.6K | ﹤0.01% | 4356 |
|
|
2018
Q2 | – | Hold |
0
| – | -$16K | – | 4324 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4181 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4167 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 4158 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 4055 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 3980 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4081 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 4054 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4056 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 4094 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 4151 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 4096 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3601 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 3430 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3654 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 3576 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 3192 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3109 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 3096 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 3094 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 3004 |
|
Other funds holding PSTV
VCM
VFT
TSS
XT
Northern Trust's PSTV Position: Q1 2026 in Review
Northern Trust held its Plus Therapeutics (PSTV) position steady in Q1 2026 at 11,732 shares worth $47.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4252.
Northern Trust first reported a position in PSTV in Q2 2021 and has held it in 11 quarters since. The position peaked at $182K in Q3 2025. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.
- Northern Trust held 11,732 shares of Plus Therapeutics worth $47.7K as of Q1 2026.
- Northern Trust left its Plus Therapeutics share count unchanged in Q1 2026.
- Plus Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #4252 holding.
- Northern Trust first reported a position in Plus Therapeutics in Q2 2021 and has held it in 11 quarters since.
- Northern Trust's Plus Therapeutics position peaked at $182K in Q3 2025.
- 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.